Christoph Wanner

Christoph Wanner

UNVERIFIED PROFILE

Are you Christoph Wanner?   Register this Author

Register author
Christoph Wanner

Christoph Wanner

Publications by authors named "Christoph Wanner"

Are you Christoph Wanner?   Register this Author

100Publications

1317Reads

45Profile Views

Cardiovascular (CV) Benefit of Empagliflozin Across the Spectrum of CV Risk Factor Control in the EMPA-REG OUTCOME Trial.

J Clin Endocrinol Metab 2020 Jun 2. Epub 2020 Jun 2.

Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/clinem/dgaa321DOI Listing
June 2020

Treatment switch in Fabry disease- a matter of dose?

J Med Genet 2020 Jun 10. Epub 2020 Jun 10.

Internal Medicine D, Department of Nephrology, Hypertension and Rheumatology and Interdisciplinary Fabry Center Münster (IFAZ), University Hospital Münster, Münster, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmedgenet-2020-106874DOI Listing
June 2020

Renal function decline in older men and women with advanced chronic kidney disease-results from the EQUAL study.

Nephrol Dial Transplant 2020 Jun 27. Epub 2020 Jun 27.

ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfaa095DOI Listing
June 2020

Empagliflozin for Patients with Presumed Resistant Hypertension: a Post Hoc Analysis of the EMPA-REG OUTCOME Trial.

Am J Hypertens 2020 May 5. Epub 2020 May 5.

Université de Lorraine, Centre d'Investigations Cliniques Plurithématique Inserm 1433, Nancy, France, CHRU de Nancy, Inserm U1116, Nancy, France, FCRIN INI-CRCT, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajh/hpaa073DOI Listing
May 2020

Comparison of different algorithms for the assessment of cardiovascular risk after kidney transplantation by the time of entering waiting list.

Clin Kidney J 2020 Apr 21;13(2):150-158. Epub 2019 Apr 21.

Division of Nephrology, Medizinische Klinik I, University of Würzburg, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ckj/sfz041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147301PMC
April 2020

Microbial U Isotope Fractionation Depends on the U(VI) Reduction Rate.

Environ Sci Technol 2020 02 30;54(4):2295-2303. Epub 2020 Jan 30.

Biosciences Division , Argonne National Laboratory , Argonne , Illinois 60439 , United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.est.9b05935DOI Listing
February 2020

A scoring system for predicting individual treatment effects of statins in type 2 diabetes patients on haemodialysis.

Eur J Prev Cardiol 2020 Feb 23:2047487320905721. Epub 2020 Feb 23.

SYNLAB Academy, SYNLAB Holding Deutschland GmbH, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2047487320905721DOI Listing
February 2020

The authors reply.

Kidney Int 2020 01;97(1):213-214

Department of Medicine, Division of Nephrology, University Health Network, University of Toronto, Canada; Department of Physiology, Division of Nephrology, University Health Network, University of Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2019.09.027DOI Listing
January 2020

Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction.

Eur Heart J Cardiovasc Pharmacother 2020 Jan 30. Epub 2020 Jan 30.

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ehjcvp/pvaa004DOI Listing
January 2020

Editorial: The role of sodium-glucose cotransporter 2 inhibitors in the management of chronic kidney disease.

Nephrol Dial Transplant 2020 01;35(Suppl 1):i1-i2

Department of Medicine, Division of Nephrology, University Hospital Würzburg, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfz282DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993193PMC
January 2020

Glucose Control and the Effect of Empagliflozin on Kidney Outcomes in Type 2 Diabetes: An Analysis From the EMPA-REG OUTCOME Trial.

Am J Kidney Dis 2019 11 27;74(5):713-715. Epub 2019 Jun 27.

Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia; Boehringer Ingelheim International GmbH, Ingelheim; Department of Medicine, Würzburg University Clinic, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2019.03.432DOI Listing
November 2019

Major adverse renal events (MARE): A proposal to unifying renal endpoints.

Nephrol Dial Transplant 2019 Nov 11. Epub 2019 Nov 11.

Division of Nephrology, University Hospital, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfz212DOI Listing
November 2019

[Anticoagulation in patients with non-valvular atrial fibrillation (nvAF) and chronic kidney disease (CKD)].

Dtsch Med Wochenschr 2019 11 21;144(23):1642-1649. Epub 2019 Nov 21.

Medizinische Klinik I, Nephrologie; Universitätsklinikum Würzburg.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-1008-5548DOI Listing
November 2019

Why systematic literature reviews in Fabry disease should include all published evidence.

Eur J Med Genet 2019 Oct 10;62(10):103702. Epub 2019 Jun 10.

INSERM U1018, University of Paris-Sud, University of Paris-Descartes, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmg.2019.103702DOI Listing
October 2019

Choice of endpoint in kidney outcome trials: considerations from the EMPA-REG OUTCOME® trial.

Nephrol Dial Transplant 2019 Sep 8. Epub 2019 Sep 8.

Department of Medicine, Würzburg University Clinic, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfz179DOI Listing
September 2019

CREDENCE and DELIGHT deliver on renal benefits.

Nat Rev Nephrol 2019 08;15(8):459-460

Division of Cardiology, University Hospital Würzburg, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41581-019-0171-2DOI Listing
August 2019

Uraemic symptom burden and clinical condition in women and men of ≥65 years of age with advanced chronic kidney disease: results from the EQUAL study.

Nephrol Dial Transplant 2019 07;34(7):1189-1196

ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfy155DOI Listing
July 2019

Sodium Glucose Cotransporter 2 Inhibition and the Visualization of Kidney Hemodynamics.

Authors:
Christoph Wanner

Circulation 2019 07 22;140(4):316-318. Epub 2019 Jul 22.

Department of Medicine, Division of Nephrology, University Hospital Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.119.040326DOI Listing
July 2019

Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Kidney Int 2019 06 30;95(6):1304-1317. Epub 2019 Apr 30.

Department of Internal Medicine, Division of Cardiology, Baylor University Medical Center, Dallas, Texas, USA; Department of Internal Medicine, Division of Cardiology, Baylor Heart and Vascular Institute, Dallas, Texas, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2019.02.022DOI Listing
June 2019

[Diabetic Kidney Disease - How to Protect the Kidney?]

Dtsch Med Wochenschr 2019 06 4;144(11):710-714. Epub 2019 Jun 4.

Medizinische Klinik und Poliklinik 1, Schwerpunkte Kardiologie und Nephrologie, Universitätsklinikum Würzburg.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-0662-1919DOI Listing
June 2019

Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year.

Clin Pharmacol Ther 2019 05 13;105(5):1224-1233. Epub 2019 Jan 13.

Department of Internal Medicine I and Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cpt.1321
Publisher Site
http://dx.doi.org/10.1002/cpt.1321DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590383PMC
May 2019

Retinopathy Outcomes With Empagliflozin Versus Placebo in the EMPA-REG OUTCOME Trial.

Diabetes Care 2019 04 31;42(4):e53-e55. Epub 2019 Jan 31.

Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc18-1355DOI Listing
April 2019

A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients.

Kidney Int 2019 04 31;95(4):983-991. Epub 2019 Jan 31.

Comprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany; Department of Medicine I, Division of Nephrology, University Hospital Würzburg, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2018.11.025DOI Listing
April 2019

Dyshidrosis is associated with reduced amplitudes in electrically evoked pain-related potentials in women with Fabry disease.

Clin Neurophysiol 2019 04 4;130(4):528-536. Epub 2019 Feb 4.

Department of Neurology, University of Würzburg, Germany; Fabry Center for Interdisciplinary Therapy (FAZIT), University of Würzburg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinph.2019.01.008DOI Listing
April 2019

Therapeutic goals in Fabry disease: Recommendations of a European expert panel, based on current clinical evidence with enzyme replacement therapy.

Mol Genet Metab 2019 03 11;126(3):210-211. Epub 2018 Apr 11.

University College London and Barts Heart Centre, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymgme.2018.04.004DOI Listing
March 2019

The effect of enzyme replacement therapy on clinical outcomes in paediatric patients with Fabry disease - A systematic literature review by a European panel of experts.

Mol Genet Metab 2019 03 26;126(3):212-223. Epub 2018 Apr 26.

French Referral Center for Fabry disease, Division of Medical Genetics and INSERM U1179, University of Versailles, Paris-Saclay University, Montigny, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymgme.2018.04.007DOI Listing
March 2019

Empagliflozin reduces the risk of a broad spectrum of heart failure outcomes regardless of heart failure status at baseline.

Eur J Heart Fail 2019 03 14;21(3):386-388. Epub 2019 Feb 14.

Centre d'Investigations Cliniques Plurithématique Inserm 1433, Université de Lorraine, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1419DOI Listing
March 2019

Will the FAbry STabilization indEX make its way to everyday clinical practice?

Clin Kidney J 2019 Feb 24;12(1):61-64. Epub 2018 Dec 24.

Department of Internal Medicine I, Division of Nephrology, University Hospital Würzburg, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ckj/sfy126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366128PMC
February 2019

Differences in Dialysis Efficacy Have Limited Effects on Protein-Bound Uremic Toxins Plasma Levels over Time.

Toxins (Basel) 2019 01 16;11(1). Epub 2019 Jan 16.

Division of Nephrology, University Hospital Würzburg, 97080 Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/toxins11010047DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356521PMC
January 2019

Hot topics in Fabry disease.

Postgrad Med J 2018 Dec 17;94(1118):709-713. Epub 2018 Dec 17.

Department of Internal Medicine, Divisions of Nephrology and Cardiology, University Hospital Würzburg, Würzburg, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/postgradmedj-2018-136056DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581083PMC
December 2018

Farewell Editorial.

J Ren Nutr 2018 11;28(6):367-368

University Hospital Wuerzburg, Department of Medicine, Division of Nephrology, Wuerzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.jrn.2018.07.002DOI Listing
November 2018

SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases.

Diabetologia 2018 10 22;61(10):2134-2139. Epub 2018 Aug 22.

Department of Internal Medicine I, Cardiology, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-018-4678-zDOI Listing
October 2018

Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials.

Lancet 2018 10 4;392(10155):1311-1320. Epub 2018 Oct 4.

Vascular Medicine Program, Sulpizio Cardiovascular Center, Division of Cardiology, Department of Medicine, University of California San Diego, La Jolla, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(18)31652-0DOI Listing
October 2018

Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control.

Circulation 2018 10;138(17):1904-1907

Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Ontario, Canada (B.Z.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.035759DOI Listing
October 2018

The ABCs in the Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease: An Introductory Remark on Expert Perspectives.

Authors:
Christoph Wanner

Clin J Am Soc Nephrol 2018 09 15;13(9):1421-1422. Epub 2018 Aug 15.

Division of Nephrology, Department of Medicine, University Hospital Würzburg, Würzburg, Germany; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.09090718DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140576PMC
September 2018

Renal Outcomes of Antidiabetic Treatment Options for Type 2 Diabetes-A Proposed MARE Definition.

Kidney Int Rep 2018 Sep 22;3(5):1030-1038. Epub 2018 Apr 22.

Division of Nephrology, University Hospital, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ekir.2018.04.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127417PMC
September 2018

Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Kidney Int 2018 08 21;94(2):231-234. Epub 2018 Jun 21.

Stanford University School of Medicine and Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2018.05.005DOI Listing
August 2018

Characterization of vertigo and hearing loss in patients with Fabry disease.

Orphanet J Rare Dis 2018 08 15;13(1):137. Epub 2018 Aug 15.

Department of Otorhinolaryngology, Head and Neck Surgery "Otto Körner", University Medical Center Rostock, Doberaner Straße 137-139, D-18057, Rostock, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13023-018-0882-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094894PMC
August 2018

Empagliflozin in women with type 2 diabetes and cardiovascular disease - an analysis of EMPA-REG OUTCOME®.

Diabetologia 2018 07 30;61(7):1522-1527. Epub 2018 Apr 30.

Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-018-4630-2DOI Listing
July 2018

Clinical impact of the alpha-galactosidase A gene single nucleotide polymorphism -10C>T: A single-center observational study.

Medicine (Baltimore) 2018 May;97(21):e10669

Department of Internal Medicine I, Division of Cardiology and Nephrology and Comprehensive Heart Failure Center Würzburg, University Hospital Würzburg.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000010669DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392711PMC
May 2018